|  | |
| Clinical data | |
|---|---|
| ATC code | None | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | 117946-91-5 | 
| PubChem (CID) | 122162 | 
| ChemSpider | 108959 | 
| ChEBI | CHEBI:131788   | 
| Chemical and physical data | |
| Formula | C19H20N2O | 
| Molar mass | 292.375 g/mol | 
| 3D model (Jmol) | Interactive image | 
| 
 | |
| 
 | |
Luzindole (N-0774), (N-acetyl-2-benzyltryptamine), is a drug used in scientific research to study the role of melatonin in the body. Luzindole acts as a selective melatonin receptor antagonist, with approximately 11- to 25-fold greater affinity for the MT2 over the MT1 receptor. In animal studies, it has been observed to disrupt the circadian rhythm as well as produce antidepressant effects.